CDTX

Cidara Therapeutics, Inc.

220.90

USD

CDTX Earnings Reports

Positive Surprise Ratio

CDTX beat 22 of 40 last estimates.

55%

Next Report

Date of Next Report

Mar 04, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$1.53

Implied change from Q3 25 (Revenue/ EPS)

-50.65%

Implied change from Q4 24 (Revenue/ EPS)

-71.51%

Cidara Therapeutics, Inc. earnings per share and revenue

On Nov 06, 2025, CDTX reported earnings of -3.10 USD per share (EPS) for Q3 25, missing the estimate of -1.37 USD, resulting in a -125.80% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.83% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 10 analysts forecast an EPS of -1.53 USD, with revenue projected to reach -- USD, implying an decrease of -50.65% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

enGene Holdings Inc. Common Stock

Report Date

Dec 22, 2025 For Q4 25

Estimate

-$0.57

Actual

-$0.73

Surprise

-25.95%

Outlook Therapeutics, Inc. Common Stock

Report Date

Dec 19, 2025 For Q4 25

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.47%

Citius Oncology, Inc. Common Stock

Report Date

Dec 23, 2025 For Q4 25

Estimate

-$0.12

Actual

-$0.06

Surprise

+50.98%

FAQ

What were Cidara Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Cidara Therapeutics, Inc. reported EPS of -$3.10, missing estimates by -125.8%, and revenue of $0.00, 0% as expectations.

How did the market react to Cidara Therapeutics, Inc.'s Q3 2025 earnings?

The stock price moved up 5.83%, changed from $98.64 before the earnings release to $104.39 the day after.

When is Cidara Therapeutics, Inc. expected to report next?

The next earning report is scheduled for Mar 04, 2026.

What are the forecasts for Cidara Therapeutics, Inc.'s next earnings report?

Based on 10 analysts, Cidara Therapeutics, Inc. is expected to report EPS of -$1.53 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.